Product
EuCorVac-19
3 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Phase III, Randomized, Observer-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate Immunogenicity and Safety of a Preventive COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and OlderStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Phase III, Randomized, Observer-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate Immunogenicity and Safety of a Preventive COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and OlderStatus: Active (not recruiting), Estimated PCD: 2023-06-23
Clinical trial
A Phase 1/2 Dose-exploration, Randomized, Observer-blind, Placebo-controlled Study to Determine Safety, Tolerance and Immunogenicity of EuCorVac-19, a Recombinant Protein Vaccine, for the Prevention of COVID-19 in Healthy AdultsStatus: Completed, Estimated PCD: 2021-10-15